Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Monthly Communication Reports in: December 2020

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Results 1-2 of 2

  • Takeda Canada Inc.
    Consultant: Ian Chesney
    Designated Public Office Holders who participated in the communication:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Economic Development, Health, Research and Development, Science and Technology
    Communication date: 2020-12-14
    Posted date: 2020-12-14
    Communication number: 364959-490505 View associated registration
  • Sunovion Pharmaceuticals Canada Inc.
    Consultant: Kate Dalgleish
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnik, Director | Policy & Economic Analysis Branch | Patented Medicine Prices Review Board (PMPRB)
    • Elena Lungu, Manager | Policy Development | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2020-12-09
    Posted date: 2021-01-15
    Communication number: 367714-489631 View associated registration
Return to Government Institutions in Monthly Communication Reports
Date Modified: